share_log

Cantor Fitzgerald Reiterates Overweight on ADC Therapeuticsto Overweight

Benzinga ·  Mar 7 16:07

Cantor Fitzgerald analyst Eric Schmidt reiterates ADC Therapeutics (NYSE:ADCT) from Overweight to Overweight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 405

Recommended

Write a comment